# EDGAR Filing Document

**Accession Number:** 0000053808
**File Stem:** 0000940400-26-011337
**Filing Date:** 2026-3
**Character Count:** 39654
**Document Hash:** dc9a817bbedfb0e1967c5b66a9cc53e6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-011337.hdr.sgml**: 20260325

**ACCESSION NUMBER**: 0000940400-26-011337

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260131

**FILED AS OF DATE**: 20260325

**DATE AS OF CHANGE**: 20260325

**PERIOD START**: 20261031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Investment Funds III
- **CENTRAL INDEX KEY:** 0000053808

**ORGANIZATION NAME:**
- **EIN:** 042694144
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-00524
- **FILM NUMBER:** 26791916

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 2129226400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS/LAUREL FUNDS TRUST
- **DATE OF NAME CHANGE:** 20181030

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DREYFUS LAUREL FUNDS TRUST
- **DATE OF NAME CHANGE:** 19941122

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LAUREL FUNDS TRUST
- **DATE OF NAME CHANGE:** 19940202

## Series and Classes Contracts Data

### BNY Mellon Global Equity Income Fund (Series ID: S000018029)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000049945 | Class A      | DEQAX           |
| C000049946 | Class C      | DEQCX           |
| C000049947 | Class I      | DQEIX           |
| C000130468 | Class Y      | DEQYX           |

## Nport-Ex

BNY Mellon Global Equity Income Fund

SCHEDULE OF INVESTMENTS

January 31, 2026 (Unaudited)

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Equity Securities - Common Stocks — 96.6%** | **Equity Securities - Common Stocks — 96.6%** | **Equity Securities - Common Stocks — 96.6%** |
| **Brazil — 1.4%** | **Brazil — 1.4%** | **Brazil — 1.4%** |
| B3 SA - Brasil Bolsa Balcao | 939720 | **2889111** |
| **China — 2.7%** | **China — 2.7%** | **China — 2.7%** |
| NARI Technology Co. Ltd., Cl. A | 877500 | 3186993 |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Cl. A | 89900 | 2451306 |
|  |  | **5638299** |
| **France — 10.2%** | **France — 10.2%** | **France — 10.2%** |
| BNP Paribas SA | 30357 | 3257518 |
| Bureau Veritas SA | 95002 | 3055773 |
| Cie de Saint-Gobain SA | 38985 | 3858532 |
| Cie Generale des Etablissements Michelin SCA | 103487 | 3847825 |
| Publicis Groupe SA | 39443 | 3932171 |
| Veolia Environnement SA | 99239 | 3718591 |
|  |  | **21670410** |
| **Germany — 4.2%** | **Germany — 4.2%** | **Germany — 4.2%** |
| Deutsche Lufthansa AG | 267309 | 2755671 |
| Fresenius SE & Co. KGaA | 49927 | 2793984 |
| Siemens AG | 11086 | 3367082 |
|  |  | **8916737** |
| **Hong Kong — 3.9%** | **Hong Kong — 3.9%** | **Hong Kong — 3.9%** |
| AIA Group Ltd. | 494400 | 5709599 |
| Hong Kong Exchanges & Clearing Ltd. | 46100 | 2538196 |
|  |  | **8247795** |
| **Indonesia — .5%** | **Indonesia — .5%** | **Indonesia — .5%** |
| Bank Rakyat Indonesia Persero Tbk PT | 4811000 | **1092369** |
| **Ireland — 3.8%** | **Ireland — 3.8%** | **Ireland — 3.8%** |
| Medtronic PLC | 37988 | 3911244 |
| Smurfit WestRock PLC | 98793 | 4112753 |
|  |  | **8023997** |
| **Italy — 2.8%** | **Italy — 2.8%** | **Italy — 2.8%** |
| Enel SpA | 285987 | 3162295 |
| Moncler SpA | 49836 | 2895271 |
|  |  | **6057566** |
| **Japan — 1.6%** | **Japan — 1.6%** | **Japan — 1.6%** |
| Tokyo Electron Ltd. | 12600 | **3376078** |
| **Netherlands — 1.5%** | **Netherlands — 1.5%** | **Netherlands — 1.5%** |
| Universal Music Group NV | 129250 | **3168244** |
| **Spain — 2.2%** | **Spain — 2.2%** | **Spain — 2.2%** |
| Industria de Diseno Textil SA | 70913 | **4629773** |
| **Sweden — 2.3%** | **Sweden — 2.3%** | **Sweden — 2.3%** |
| Sandvik AB | 73553 | 2910615 |
| SKF AB, Cl. B | 78135 | 2038110 |
|  |  | **4948725** |
| **Taiwan — 1.0%** | **Taiwan — 1.0%** | **Taiwan — 1.0%** |
| MediaTek, Inc. | 37000 | **2065113** |
| **United Kingdom — 10.7%** | **United Kingdom — 10.7%** | **United Kingdom — 10.7%** |
| AstraZeneca PLC | 26347 | 4891450 |
| BAE Systems PLC | 166819 | 4498817 |
| Barclays PLC | 618512 | 4131069 |

---

**3**

------

*SCHEDULE OF INVESTMENTS (Unaudited) (continued)*

------

---

| | | |
|:---|:---|:---|
| Description | Shares | Value ($) |
| **Equity Securities - Common Stocks — 96.6% (continued)** | **Equity Securities - Common Stocks — 96.6% (continued)** | **Equity Securities - Common Stocks — 96.6% (continued)** |
| **United Kingdom — 10.7% (continued)** | **United Kingdom — 10.7% (continued)** | **United Kingdom — 10.7% (continued)** |
| GSK PLC | 145414 | 3733808 |
| Persimmon PLC | 122286 | 2354251 |
| Unilever PLC | 46387 | 3145546 |
|  |  | **22754941** |
| **United States — 47.8%** | **United States — 47.8%** | **United States — 47.8%** |
| Bristol-Myers Squibb Co. | 52376 | 2883299 |
| Cisco Systems, Inc. | 72455 | 5674676 |
| CME Group, Inc. | 23185 | 6701856 |
| ConocoPhillips | 33219 | 3462417 |
| Diamondback Energy, Inc. | 25969 | 4257618 |
| Dominion Energy, Inc. | 70896 | 4265812 |
| Elevance Health, Inc. | 9943 | 3437693 |
| Exelon Corp. | 93222 | 4174481 |
| Expand Energy Corp. | 21535 | 2420749 |
| First Horizon Corp. | 129721 | 3176867 |
| Gilead Sciences, Inc. | 42880 | 6086816 |
| International Paper Co. | 48482 | 1954794 |
| Johnson & Johnson | 22255 | 5057449 |
| MetLife, Inc. | 37289 | 2941356 |
| Molson Coors Beverage Co., Cl. B | 53618 | 2575809 |
| Old Republic International Corp. | 84978 | 3328588 |
| Omnicom Group, Inc. | 38555 | 2970277 |
| PepsiCo, Inc. | 21821 | 3352360 |
| Pfizer, Inc. | 159457 | 4216043 |
| Phillips 66 | 27434 | 3938425 |
| PPG Industries, Inc. | 28230 | 3264235 |
| Starbucks Corp. | 45982 | 4228045 |
| Sysco Corp. | 42953 | 3601609 |
| Texas Instruments, Inc. | 19717 | 4249999 |
| The Home Depot, Inc. | 10084 | 3777366 |
| The Kraft Heinz Company | 80026 | 1899817 |
| UnitedHealth Group, Inc. | 12442 | 3569983 |
|  |  | **101468439** |
| &nbsp;&nbsp;&nbsp; **Total Equity Securities - Common Stocks** <br>(cost $164,063,978)<br>|  | **204947597** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | Preferred <br>Dividend <br>Rate (%)<br>|  |  |
| **Equity Securities - Preferred Stocks — 1.7%** |  |  |  |
| **South Korea — 1.7%** |  |  |  |
| &nbsp;&nbsp;&nbsp; Samsung Electronics Co. Ltd. <br>(cost $1,402,981)<br>| 1.45 | 44191 | **3518153** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**4**

------

---

| | | | |
|:---|:---|:---|:---|
| Description | 1-Day <br>Yield (%)<br>| Shares | Value ($) |
| **Investment Companies — 1.1%** |  |  |  |
| **Registered Investment Companies — 1.1%** | **Registered Investment Companies — 1.1%** | **Registered Investment Companies — 1.1%** | **Registered Investment Companies — 1.1%** |
| &nbsp;&nbsp;&nbsp; Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional <br> Shares<sup>(a)</sup> <br>(cost $2,351,099)<br>| 3.72 | 2351099 | **2351099** |
| **Total Investments** (cost $167,818,058) |  | **99.4%**<br>| **210816849** |
| **Cash and Receivables (Net)** |  | **.6%**<br>| **1282537** |
| **Net Assets** |  | **100.0%**<br>| **212099386** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> *Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's* *prospectus.*

*See notes to schedule of investments.*

**5**

------

Schedule of Investments

BNY Mellon Global Equity Income Fund

January 31, 2026 (Unaudited)

The following is a summary of the inputs used as of January 31, 2026 in valuing the fund's investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1 -** <br>**Unadjusted** <br>**Quoted Prices**<br>| **Level 2- Other** <br>**Significant** <br>**Observable Inputs**<br>| **Level 3-** <br>**Significant** <br>**Unobservable** <br>**Inputs**<br>| **Total** |
| **Assets ($)** |  |  |  |  |
| Investments in Securities:<sup>†</sup> <br>|  |  |  |  |
| Equity Securities - Common Stocks | &nbsp;&nbsp; 112381547 | &nbsp;&nbsp; 92566050<sup>††</sup> | &nbsp;&nbsp; — | &nbsp;&nbsp; **204947597** |
| Equity Securities - Preferred Stocks | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 3518153<sup>††</sup> <br>| &nbsp;&nbsp; — | &nbsp;&nbsp; **3518153** |
| Investment Companies | &nbsp;&nbsp;&nbsp;&nbsp; 2351099 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; **2351099** |
|  | &nbsp;&nbsp; **114732646** | &nbsp;&nbsp; **96084203** | &nbsp;&nbsp; **—** | &nbsp;&nbsp; **210816849** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <sup>†</sup> <br>| *See Schedule of Investments for additional detailed categorizations, if any.* |
| <sup>††</sup> <br>| *Securities classified within Level 2 at period end as the values were determined pursuant to the fund's fair valuation procedures.* |

---

**6**

------

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") is the exclusive reference of authoritative U.S. generally accepted accounting principles ("GAAP") recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission ("SEC") under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund's financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund's investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

**Level 1**—unadjusted quoted prices in active markets for identical investments.

**Level 2**—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

**Level 3**—significant unobservable inputs (including the fund's own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund's investments are as follows:

The Trust's Board of Trustees (the "Board") has designated the Adviser as the fund's valuation designee to make all fair value determinations with respect to the fund's portfolio investments, subject to the Board's oversight and pursuant to Rule 2a-5 under the Act.

Equity investments generally are valued at the last sale price on the day of valuation on the securities exchange or national securities market on which such securities primarily are traded. Securities listed on Nasdaq markets generally will be valued at the official closing price. If there are no transactions in a security, or no official closing prices for a Nasdaq market-listed security on that day, the security will be valued at the average of the most recent bid and asked prices. Bid price is used when no asked price is available. Open short positions for which there is no sale price on a given day are valued at the lowest asked price. Investments in other open-end investment companies are valued at their reported NAVs each day. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Fair value of foreign equity securities may be determined with the assistance of a pricing service using correlations between the movement of prices of foreign securities and indexes of domestic securities and other appropriate indicators, such as closing market prices of relevant American Depositary Receipts and futures contracts. The valuation of a security based on this fair value process may differ from the security's most recent closing price and from the prices used by other mutual funds to calculate their NAVs. Foreign securities held by a fund may trade on days when the fund does not calculate its NAV and thus may affect the fund's NAV on days when investors will not be able to purchase or sell (redeem) fund shares. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

Restricted securities, as well as securities or other assets for which recent market quotations or official closing prices are not readily available or are determined not to reflect accurately fair value (such as when the value of a security has been materially affected by events occurring after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its NAV), or which are not valued by the Service, are valued at fair value as determined in good faith based on procedures approved by the Board. Fair value of investments is determined by the Adviser, as the fund's Valuation Designee pursuant to Rule 2a-5 under the Act, using such information as it deems appropriate under the circumstances. The factors that may be considered when fair valuing a security include fundamental analytical data, the nature and duration of restrictions on disposi

**7**

------

tion, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. Using fair value to price investments may result in a value that is different from a security's most recent closing price and from the prices used by other mutual funds to calculate their net asset values. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

Market quotations of foreign securities in foreign currencies and any fund assets or liabilities initially expressed in terms of foreign currency are translated into U.S. dollars at the spot rate.

At January 31, 2026, accumulated net unrealized appreciation on investments was $42,998,791, consisting of $45,713,651 gross unrealized appreciation and $2,714,860 gross unrealized depreciation.

At January 31, 2026, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Schedule of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.

**8**

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** BNY Mellon Investment Funds III

- **b. Investment Company Act file number:** 811-00524

- **c. CIK number of Registrant:** 0000053808

- **d. LEI of Registrant:** 549300DOYFL5R4I71F16

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 240 Greenwich Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10286

  - **Telephone number:** 212-922-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** BNY Mellon Global Equity Income Fund

- **b. EDGAR series identifier (if any):** S000018029

- **c. LEI of Series:** 549300YDM1PXRAWO0B11

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-10-31

- **b. Date as of which information is reported:** 2026-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $212465358.27

**Total Liabilities:** $233840.26

**Net Assets:** $212231518.01

**Cash Not Reported:** $379045.38

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000049945 | 2.98%                | 1.32%                | 6.08%                |
| Class ID C000049946 | 2.87%                | 1.23%                | 6.03%                |
| Class ID C000049947 | 2.95%                | 1.37%                | 6.14%                |
| Class ID C000130468 | 2.95%                | 1.38%                | 6.14%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $963017.85               | $4649174.23                                |
| Month 2  | $2601002.34              | $-93002.20                                 |
| Month 3  | $4882363.81              | $7067150.75                                |

### Schedule of Portfolio Investments

| Name                           | Title                                                             | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ConocoPhillips                 | ConocoPhillips                                                    | CUSIP: 20825C104<br>LEI: WPTL2Z3FIYTHSP5V2253 | Long             | EC               | CORP              | US        |     33219 | NS      | $3462416.37   | 1.63%             |  |  |  | No            |                  1 | On Loan: No      |
| BNP Paribas SA                 | BNP Paribas SA                                                    | CUSIP: 000000000<br>LEI: R0MUWSFPU8MPRO8K5P83 | Long             | EC               | CORP              | FR        |     30357 | NS      | $3257517.93   | 1.53%             |  |  |  | No            |                  2 | On Loan: No      |
| Enel SpA                       | Enel SpA                                                          | CUSIP: 000000000<br>LEI: WOCMU6HCI0OJWNPRZS33 | Long             | EC               | CORP              | IT        |    285987 | NS      | $3162294.91   | 1.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Diamondback Energy Inc         | Diamondback Energy Inc                                            | CUSIP: 25278X109<br>LEI: 549300R22LSX6OHWEN64 | Long             | EC               | CORP              | US        |     25969 | NS      | $4257617.55   | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SKF AB                         | SKF AB                                                            | CUSIP: 000000000<br>LEI: 549300B6HWYEE57O8J84 | Long             | EC               | CORP              | SE        |     73945 | NS      | $1928815.97   | 0.91%             |  |  |  | No            |                  2 | On Loan: No      |
| Bureau Veritas SA              | Bureau Veritas SA                                                 | CUSIP: 000000000<br>LEI: 969500TPU5T3HA5D1F11 | Long             | EC               | CORP              | FR        |     95002 | NS      | $3055773.08   | 1.44%             |  |  |  | No            |                  2 | On Loan: No      |
| Persimmon PLC                  | Persimmon PLC                                                     | CUSIP: 000000000<br>LEI: 213800XI72Y57UWN6F31 | Long             | EC               | CORP              | GB        |    122286 | NS      | $2354250.87   | 1.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Tokyo Electron Ltd             | Tokyo Electron Ltd                                                | CUSIP: 000000000<br>LEI: 549300H5LSF8DP3RIJ34 | Long             | EC               | CORP              | JP        |     12600 | NS      | $3376078.06   | 1.59%             |  |  |  | No            |                  2 | On Loan: No      |
| International Paper Co         | International Paper Co                                            | CUSIP: 460146103<br>LEI: 824LMFJDH41EY779Q875 | Long             | EC               | CORP              | US        |     48482 | NS      | $1954794.24   | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Bank Rakyat Indonesia Persero  | Bank Rakyat Indonesia Persero Tbk PT                              | CUSIP: 000000000<br>LEI: 254900HB6S4B12GBNP64 | Long             | EC               | CORP              | ID        |   4811000 | NS      | $1092368.72   | 0.51%             |  |  |  | No            |                  2 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                                                   | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     26347 | NS      | $4891450.33   | 2.30%             |  |  |  | No            |                  2 | On Loan: No      |
| Unilever PLC                   | Unilever PLC                                                      | CUSIP: 000000000<br>LEI: 549300MKFYEKVRWML317 | Long             | EC               | CORP              | GB        |     46387 | NS      | $3145546.15   | 1.48%             |  |  |  | No            |                  2 | On Loan: No      |
| Phillips 66                    | Phillips 66                                                       | CUSIP: 718546104<br>LEI: 5493005JBO5YSIGK1814 | Long             | EC               | CORP              | US        |     27434 | NS      | $3938425.04   | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc            | Elevance Health Inc                                               | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |      9943 | NS      | $3437692.82   | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                  | Medtronic PLC                                                     | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |     37988 | NS      | $3911244.48   | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Kraft Heinz Co/The             | Kraft Heinz Co/The                                                | CUSIP: 500754106<br>LEI: 9845007488EC87F5AF14 | Long             | EC               | CORP              | US        |     80026 | NS      | $1899817.24   | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| MetLife Inc                    | MetLife Inc                                                       | CUSIP: 59156R108<br>LEI: C4BXATY60WC6XEOZDX54 | Long             | EC               | CORP              | US        |     37289 | NS      | $2941356.32   | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Barclays PLC                   | Barclays PLC                                                      | CUSIP: 000000000<br>LEI: 213800LBQA1Y9L22JB70 | Long             | EC               | CORP              | GB        |    618512 | NS      | $4131068.68   | 1.95%             |  |  |  | No            |                  2 | On Loan: No      |
| BAE Systems PLC                | BAE Systems PLC                                                   | CUSIP: 000000000<br>LEI: 8SVCSVKSGDWMW2QHOH83 | Long             | EC               | CORP              | GB        |    166819 | NS      | $4498817.19   | 2.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Fresenius SE & Co KGaA         | Fresenius SE & Co KGaA                                            | CUSIP: 000000000<br>LEI: XDFJ0CYCOO1FXRFTQS51 | Long             | EC               | CORP              | DE        |     49927 | NS      | $2793983.86   | 1.32%             |  |  |  | No            |                  2 | On Loan: No      |
| Moncler SpA                    | Moncler SpA                                                       | CUSIP: 000000000<br>LEI: 815600EBD7FB00525B20 | Long             | EC               | CORP              | IT        |     49836 | NS      | $2895271.19   | 1.36%             |  |  |  | No            |                  2 | On Loan: No      |
| Sandvik AB                     | Sandvik AB                                                        | CUSIP: 000000000<br>LEI: 5299008ZUAXN43LVZF54 | Long             | EC               | CORP              | SE        |     73553 | NS      | $2910614.98   | 1.37%             |  |  |  | No            |                  2 | On Loan: No      |
| Michelin                       | Cie Generale des Etablissements Michelin SCA                      | CUSIP: 000000000<br>LEI: 549300SOSI58J6VIW052 | Long             | EC               | CORP              | FR        |    103487 | NS      | $3847824.48   | 1.81%             |  |  |  | No            |                  2 | On Loan: No      |
| PepsiCo Inc                    | PepsiCo Inc                                                       | CUSIP: 713448108<br>LEI: FJSUNZKFNQ5YPJ5OT455 | Long             | EC               | CORP              | US        |     21821 | NS      | $3352360.23   | 1.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Shenzhen Mindray Bio-Medical E | Shenzhen Mindray Bio-Medical Electronics Co Ltd                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | CN        |     89900 | NS      | $2451306.13   | 1.16%             |  |  |  | No            |                  2 | On Loan: No      |
| UnitedHealth Group Inc         | UnitedHealth Group Inc                                            | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     11383 | NS      | $3266124.19   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Smurfit WestRock PLC           | Smurfit WestRock PLC                                              | CUSIP: 000000000<br>LEI: 635400EGSEOPDW2EXS14 | Long             | EC               | CORP              | IE        |     98793 | NS      | $4112752.59   | 1.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                                               | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     42880 | NS      | $6086816.00   | 2.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                     | Pfizer Inc                                                        | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    159457 | NS      | $4216043.08   | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Siemens AG                     | Siemens AG                                                        | CUSIP: 000000000<br>LEI: W38RGI023J3WT1HWRP32 | Long             | EC               | CORP              | DE        |     11086 | NS      | $3367081.88   | 1.59%             |  |  |  | No            |                  2 | On Loan: No      |
| B3 SA - Brasil Bolsa Balcao    | B3 SA - Brasil Bolsa Balcao                                       | CUSIP: 000000000<br>LEI: 4GTK5S46E6H318LMDS44 | Long             | EC               | CORP              | BR        |   1045564 | NS      | $3214521.97   | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Music Group NV       | Universal Music Group NV                                          | CUSIP: 000000000<br>LEI: 724500GJBUL3D9TW9Y18 | Long             | EC               | CORP              | NL        |    129250 | NS      | $3168243.63   | 1.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Samsung Electronics Co Ltd     | Samsung Electronics Co Ltd                                        | CUSIP: 000000000<br>LEI: 9884007ER46L6N7EI764 | Long             | EP               | CORP              | KR        |     44191 | NS      | $3518153.15   | 1.66%             |  |  |  | No            |                  2 | On Loan: No      |
| HKEX                           | Hong Kong Exchanges & Clearing Ltd                                | CUSIP: 000000000<br>LEI: 213800YTVSXYQN17BW16 | Long             | EC               | CORP              | HK        |     46100 | NS      | $2538196.30   | 1.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Cisco Systems Inc              | Cisco Systems Inc                                                 | CUSIP: 17275R102<br>LEI: 549300LKFJ962MZ46593 | Long             | EC               | CORP              | US        |     72455 | NS      | $5674675.60   | 2.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Old Republic International Cor | Old Republic International Corp                                   | CUSIP: 680223104<br>LEI: 549300IV6O2YY2A1KH37 | Long             | EC               | CORP              | US        |     84978 | NS      | $3328588.26   | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS INSTITUTIONAL PREFERRE | DREYFUS INSTITUTIONAL PREFERRED GOVERNMENT PLUS MONEY MARKET FUND | CUSIP: 000000000<br>LEI: 549300RBWL04JG8SIX57 | Long             | STIV             | RF                | US        |   2351099 | NS      | $2351098.99   | 1.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Home Depot Inc/The             | Home Depot Inc/The                                                | CUSIP: 437076102<br>LEI: QEKMOTMBBKA8I816DO57 | Long             | EC               | CORP              | US        |     10084 | NS      | $3777365.56   | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| AIA Group Ltd                  | AIA Group Ltd                                                     | CUSIP: 000000000<br>LEI: ZP5ILWVSYE4LJGMMVD57 | Long             | EC               | CORP              | HK        |    494400 | NS      | $5709598.85   | 2.69%             |  |  |  | No            |                  2 | On Loan: No      |
| MediaTek Inc                   | MediaTek Inc                                                      | CUSIP: 000000000<br>LEI: 254900UEGBK1I4DM4E14 | Long             | EC               | CORP              | TW        |     37000 | NS      | $2065113.09   | 0.97%             |  |  |  | No            |                  2 | On Loan: No      |
| Expand Energy Corp             | Expand Energy Corp                                                | CUSIP: 165167735<br>LEI: X2MT1W32SPAZ9WSKLE78 | Long             | EC               | CORP              | US        |     21535 | NS      | $2420749.35   | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Industria de Diseno Textil SA  | Industria de Diseno Textil SA                                     | CUSIP: 000000000<br>LEI: 549300TTCXZOGZM2EY83 | Long             | EC               | CORP              | ES        |     70913 | NS      | $4629772.52   | 2.18%             |  |  |  | No            |                  2 | On Loan: No      |
| Starbucks Corp                 | Starbucks Corp                                                    | CUSIP: 855244109<br>LEI: OQSJ1DU9TAOC51A47K68 | Long             | EC               | CORP              | US        |     45982 | NS      | $4228044.90   | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| First Horizon Corp             | First Horizon Corp                                                | CUSIP: 320517105<br>LEI: TF3RXI1ZB1TQ30H9JV10 | Long             | EC               | CORP              | US        |    129721 | NS      | $3176867.29   | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Veolia Environnement SA        | Veolia Environnement SA                                           | CUSIP: 000000000<br>LEI: 969500LENY69X51OOT31 | Long             | EC               | CORP              | FR        |     99239 | NS      | $3718590.75   | 1.75%             |  |  |  | No            |                  2 | On Loan: No      |
| CME Group Inc                  | CME Group Inc                                                     | CUSIP: 12572Q105<br>LEI: LCZ7XYGSLJUHFXXNXD88 | Long             | EC               | CORP              | US        |     23185 | NS      | $6701856.10   | 3.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co        | Bristol-Myers Squibb Co                                           | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     52376 | NS      | $2883298.80   | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Texas Instruments Inc          | Texas Instruments Inc                                             | CUSIP: 882508104<br>LEI: WDJNR2L6D8RWOEB8T652 | Long             | EC               | CORP              | US        |     19717 | NS      | $4249999.35   | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                                                 | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     22255 | NS      | $5057448.75   | 2.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Deutsche Lufthansa AG          | Deutsche Lufthansa AG                                             | CUSIP: 000000000<br>LEI: 529900PH63HYJ86ASW55 | Long             | EC               | CORP              | DE        |    267309 | NS      | $2755671.27   | 1.30%             |  |  |  | No            |                  2 | On Loan: No      |
| PPG Industries Inc             | PPG Industries Inc                                                | CUSIP: 693506107<br>LEI: 549300BKPEP01R3V6C59 | Long             | EC               | CORP              | US        |     28230 | NS      | $3264234.90   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Cie de Saint-Gobain SA         | Cie de Saint-Gobain SA                                            | CUSIP: 000000000<br>LEI: NFONVGN05Z0FMN5PEC35 | Long             | EC               | CORP              | FR        |     38985 | NS      | $3858532.34   | 1.82%             |  |  |  | No            |                  2 | On Loan: No      |
| Molson Coors Beverage Co       | Molson Coors Beverage Co                                          | CUSIP: 60871R209<br>LEI: 54930073LBBH6ZCBE225 | Long             | EC               | CORP              | US        |     53618 | NS      | $2575808.72   | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicom Group Inc              | Omnicom Group Inc                                                 | CUSIP: 681919106<br>LEI: HKUPACFHSSASQK8HLS17 | Long             | EC               | CORP              | US        |     38555 | NS      | $2970277.20   | 1.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelon Corp                    | Exelon Corp                                                       | CUSIP: 30161N101<br>LEI: 3SOUA6IRML7435B56G12 | Long             | EC               | CORP              | US        |     93222 | NS      | $4174481.16   | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Publicis Groupe SA             | Publicis Groupe SA                                                | CUSIP: 000000000<br>LEI: 2138004KW8BV57III342 | Long             | EC               | CORP              | FR        |     39443 | NS      | $3932170.92   | 1.85%             |  |  |  | No            |                  2 | On Loan: No      |
| Sysco Corp                     | Sysco Corp                                                        | CUSIP: 871829107<br>LEI: 5RGWIFLMGH3YS7KWI652 | Long             | EC               | CORP              | US        |     42953 | NS      | $3601609.05   | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| NARI Technology Co Ltd         | NARI Technology Co Ltd                                            | CUSIP: 000000000<br>LEI: 3003006IGH1W58MAQM05 | Long             | EC               | CORP              | CN        |    877500 | NS      | $3186992.96   | 1.50%             |  |  |  | No            |                  2 | On Loan: No      |
| Dominion Energy Inc            | Dominion Energy Inc                                               | CUSIP: 25746U109<br>LEI: ILUL7B6Z54MRYCF6H308 | Long             | EC               | CORP              | US        |     70896 | NS      | $4265812.32   | 2.01%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                        | GSK PLC                                                           | CUSIP: 000000000<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |    145414 | NS      | $3733808.04   | 1.76%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-25

**Name of Applicant:** BNY Mellon Investment Funds III

**Signature:** James Windels

**Name of Signer:** James Windels

**Title:** Treasurer